Characterizing Elephant MDM2's Role in p53 Regulation

Peto's paradox, which describes the absence of a strong correlation between cancer risk, body size, and lifespan among species, raises intriguing questions about natural cancer resistance mechanisms. Elephants have evolved unique adaptations that reduce cancer susceptibility despite their large body size and long lifespan. Central to this phenomenon is p53, a key tumor suppressor regulated by MDM2. Our research investigates the structural and functional differences between elephantine MDM2 and its human counterpart. Utilizing human cellular models, we demonstrate that elephantine MDM2 variants enhance p53's activity, leading to increased p53 occupancy on its response elements, and modulate p53-mediated transcription in a stress-dependent manner. These findings shed light on the molecular basis of cancer resistance in elephants and provide a foundation for developing innovative cancer therapies targeting MDM2-p53 interactions.